2021年までのまとめ 英語総説 (English review articles)

8) Kanazawa I, Inaba M, Inoue D, Uenishi K, Saito M, Shiraki M, Suzuki A, Takeuchi Y, Hagino H, Fujiwara S, Sugimoto T, from the Japan Osteoporosis Society Lifestyle diseases-related Fracture Risk Investigation Committee. Executive summary of Clinical Practice Guide on fracture risk in lifestyle diseases. Journal of Bone Mineral Metabolism, 2020; 38(6): 746-758.
7) Kanazawa I, Sugimoto T. Diabetes mellitus-induced bone fragility. Internal Medicine, 2018; 57(19): 2773-2785.
6) Kanazawa I, Sugimoto T. The mechanism of bone fragility in diabetes mellitus. Glycative Stress Research, 2017; 4(4): 266-274.
5) Kanazawa I. Interaction between bone and glucose metabolism. Endocrine Journal, 2017; 64(11): 1043-1053.
4) Kanazawa I. Association of the roles of advanced glycation end products and osteocalcin between bone metabolism and vascular failure. Vascular Failure 2017; 1(1): 30-38.
3) Kanazawa I. Osteocalcin as a hormone regulating glucose metabolism. World Journal of Diabetes 2015; 6(18): 1345-1354.
2) Kanazawa I. Adiponectin in metabolic bone disease. Current Medicinal Chemistry 2012; 19(32): 5481-5491.
1) Kanazawa I. The role of adipokines in bone homeostasis. Adipobiology 2011; 3: 37-48.

Posting order
金沢一平 糖尿病と骨粗しょう症専門医からの提案